South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig
This article was originally published in The Pink Sheet Daily
To ramp up pharmaceutical sales, the company may have to overcome some considerable challenges directly linked to the country's increasingly indebted health care system.
You may also be interested in...
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs' new pricing policy, currently being re-crafted, is drawing criticism from the country's domestic generic drug makers because part of the new policy is calling for much lower prices on generics and original products coming off patent protection
SHANGHAI - After pressuring international pharmaceutical companies to drastically reduce prices on a list of basic drugs, with mixed results, the Philippines government is imposing price caps by executive order in a move that will take effect August 15
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.